What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT06319378 - Cancer Related Major Depression Treated With a Single Dose of Psilocybin
Clinical Trial in Gothenburg, Sweden
The goal of this randomized placebo controlled trial is to compare the antidepressant effect of a single oral dose of psilocybin 25 mg compared to 1 mg in 100 patients with cancer related major depressive disorder. The main question it aims to answer is: The primary objective of this study is to evaluate the efficacy of a single 25 mg oral dose of psilocybin for major depressive disorder (MDD) compared to an activ... Source record lists lead sponsor Section for Affective Disorders; Northern Stockholm Psychiatry and overall status Recruiting.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT06319378
- Last Verified
- 2026-06-12
Location
region Västra Götaland, Gothenburg, Göteborg
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT06319378; status Recruiting; sponsor Section for Affective Disorders; Northern Stockholm Psychiatry.
Source: https://clinicaltrials.gov/study/NCT06319378
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.